126 related articles for article (PubMed ID: 3141911)
1. Disposition of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice before and after monoamine oxidase and catecholamine reuptake inhibition.
Lydén-Sokolowski A; Larsson BS; Lindquist NG
Pharmacol Toxicol; 1988 Aug; 63(2):75-80. PubMed ID: 3141911
[TBL] [Abstract][Full Text] [Related]
2. Influence of monoamine oxidase inhibitors and a dopamine uptake blocker on the distribution of 11C-N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, 11C-MPTP, in the head of the rhesus monkey.
Hartvig P; Larsson BS; Lindberg BS; Oreland L; Gullberg P; Långström B; Rimland A; Lundqvist H; Malmborg P; Lindquist NG
Acta Neurol Scand; 1986 Jul; 74(1):10-6. PubMed ID: 3490110
[TBL] [Abstract][Full Text] [Related]
3. Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in mice.
Fuller RW; Hemrick-Luecke SK; Kindt MV; Heikkila RE
Life Sci; 1988; 42(3):263-71. PubMed ID: 3121972
[TBL] [Abstract][Full Text] [Related]
4. Differential time course of protection by monoamine oxidase inhibition and uptake inhibition against MPTP neurotoxicity on central catecholamine neurons in mice.
Sundström E; Jonsson G
Eur J Pharmacol; 1986 Mar; 122(2):275-8. PubMed ID: 3486769
[TBL] [Abstract][Full Text] [Related]
5. Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites.
Itzhak Y; Mash D; Zhang SH; Stein I
Mol Pharmacol; 1991 Mar; 39(3):385-93. PubMed ID: 1848660
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological interference with the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in the mouse.
Sundström E; Jonsson G
Eur J Pharmacol; 1985 Apr; 110(3):293-9. PubMed ID: 3874083
[TBL] [Abstract][Full Text] [Related]
7. Deprenyl antagonizes acute lethality of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
Fuller RW; Hemrick-Luecke SK; Perry KW
J Pharmacol Exp Ther; 1988 Nov; 247(2):531-5. PubMed ID: 3141609
[TBL] [Abstract][Full Text] [Related]
8. The effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal and limbic catecholamine neurones in white and black mice. Antagonism by monoamine oxidase inhibitors.
Bradbury AJ; Costall B; Jenner PG; Kelly ME; Marsden CD; Naylor RJ
Neuropharmacology; 1986 Aug; 25(8):897-904. PubMed ID: 3022182
[TBL] [Abstract][Full Text] [Related]
9. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correspondence of its binding sites to monoamine oxidase in rat brain, and inhibition of dopamine oxidative deamination in vivo and in vitro.
Bocchetta A; Piccardi MP; Del Zompo M; Pintus S; Corsini GU
J Neurochem; 1985 Sep; 45(3):673-6. PubMed ID: 3928808
[TBL] [Abstract][Full Text] [Related]
10. [3H]tryptamine binding sites are not identical to monoamine oxidase in rat brain.
Perry DC; Grimm LJ; Kettler KG; Kellar KJ
J Neurochem; 1988 Nov; 51(5):1535-40. PubMed ID: 3139835
[TBL] [Abstract][Full Text] [Related]
11. Distribution of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in experimental animals studied by postiron emission tomography and whole body autoradiography.
Hartvig P; Lindquist NG; Aquilonius SM; d'Argy R; Bergström K; Bondesson U; Eckernäs SA; Gullberg P; Larsson BS; Lindberg B
Life Sci; 1986 Jan; 38(1):89-97. PubMed ID: 3484535
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain.
Fuller RW; Robertson DW; Hemrick-Luecke SK
J Pharmacol Exp Ther; 1987 Feb; 240(2):415-20. PubMed ID: 3100775
[TBL] [Abstract][Full Text] [Related]
13. Primate-rodent 3H-MPTP binding differences, and biotransformation of MPTP to a reactive intermediate in vitro.
Corsini GU; Pintus S; Bocchetta A; Piccardi MP; Del Zompo M
J Neural Transm Suppl; 1986; 22():55-60. PubMed ID: 3097260
[TBL] [Abstract][Full Text] [Related]
14. Autoradiography of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): uptake in the monoaminergic pathways and in melanin containing tissues.
Lydén A; Bondesson U; Larsson BS; Lindquist NG; Olsson LI
Acta Pharmacol Toxicol (Copenh); 1985 Aug; 57(2):130-5. PubMed ID: 3877403
[TBL] [Abstract][Full Text] [Related]
15. Studies on the mechanism of action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Cohen G; Mytilineou C
Life Sci; 1985 Jan; 36(3):237-42. PubMed ID: 3917526
[TBL] [Abstract][Full Text] [Related]
16. Prevention of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic toxicity in mice by MDL 72145, a selective inhibitor of MAO-B.
Kindt MV; Heikkila RE
Life Sci; 1986 Apr; 38(16):1459-62. PubMed ID: 3084895
[TBL] [Abstract][Full Text] [Related]
17. Age-dependent effects of the 2'-methyl analog of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine: prevention by inhibitors of monoamine oxidase B.
Finnegan KT; Irwin I; Delanney LE; Langston JW
J Pharmacol Exp Ther; 1995 May; 273(2):716-20. PubMed ID: 7752075
[TBL] [Abstract][Full Text] [Related]
18. Amphetamine-metabolites of deprenyl involved in protection against neurotoxicity induced by MPTP and 2'-methyl-MPTP.
Sziráki I; Kardos V; Patthy M; Pátfalusi M; Gaál J; Solti M; Kollár E; Singer J
J Neural Transm Suppl; 1994; 41():207-19. PubMed ID: 7931228
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolic activity of porcine FAD-containing monooxygenase by selective monoamine oxidase-B inhibitors.
Wu RF; Ichikawa Y
FEBS Lett; 1995 Jan; 358(2):145-8. PubMed ID: 7828725
[TBL] [Abstract][Full Text] [Related]
20. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors.
Heikkila RE; Manzino L; Cabbat FS; Duvoisin RC
Nature; 1984 Oct 4-10; 311(5985):467-9. PubMed ID: 6332989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
